In this article, the author discusses the need to build an economic value strategy that addresses the sometimes disparate perspectives of key stakeholders. To read the article, click the link below.
Consequences of counterfeit pharmaceutical product sales
Recently, both the FDA and EMA have raised concerns about counterfeit drug products, including GLP-1s used for weight loss and diabetes, being marketed in the...